Skip to main content

Branded

  • Sandoz announces FDA approval, U.S. launch of chemotherapy drug

    PRINCETON, N.J. — The Food and Drug Administration has approved a chemotherapy drug made by Sandoz, the drug maker said Tuesday.

    Sandoz, the generics division of Swiss drug maker Novartis, announced the approval and launch of docetaxel, an injectable chemotherapy drug that the company said was the 11th cancer drug it has launched in the United States.

  • AstraZeneca's Brilinta now available

    WILMINGTON, Del. — A new drug made by AstraZeneca is available in pharmacies following its regulatory approval in July, the company said Monday.

    AstraZeneca announced the availability of the anti-platelet drug Brilinta (ticagrelor) for reducing the rate of thrombotic cardiovascular events in patients with acute coronary syndrome.

    The Food and Drug Administration approved Brilinta on July 20. AstraZeneca said the drug has been shown to reduce the rates of cardiovascular death, heart attacks and stroke, compared with other drugs on the market.

  • Needle disposal solution offered exclusively at Walgreens

    HOUSTON — Sharps Compliance on Monday announced that Walgreens will be the exclusive retailer for the company's Complete Needle Collection & Disposal System.

    "When it comes to patient care and safety, this innovative disposal alternative can help provide a convenient option for patients," stated Suzanne Hansen, Walgreens group VP pharmacy operations. "Customers often ask about what to do with these types of needles, and now our pharmacists have another option to discuss with patients."

  • Valeant completes Sanitas Group acquisition

    MISSISSAUGA, Ontario — Canada-based drug maker Valeant Pharmaceuticals International has acquired a Kaunas, Lithuania-based specialty pharmaceutical company.

    Valeant said it completed its acquisition of Sanitas Group, which operates in Central and Eastern Europe and Russia markets.

    The deal, which initially was announced by Valeant in May, was valued at EUR314 million (about $450 million) in cash.

  • FDA approves first new Hodgkin's lymphoma treatment in 34 years

    SILVER SPRING, Md. — The Food and Drug Administration has approved a new biotech drug for treating two types of lymphoma, the agency said Friday.

  • OTCs now available to patients, employees at hospital pharmacy kiosks

    SAN DIEGO — Asteres, a provider of 24/7 automated pharmacy kiosks, earlier this week announced that Guthrie Health is the first hospital pharmacy to offer OTC products in addition to prescriptions at their ScriptCenter kiosk.

    Hospitals are installing ScriptCenter to provide a quick and convenient prescription drop-off and pickup service to hospital employees, especially those who work when the pharmacy is closed, the company stated.

  • Board member at Valeant steps down

    MISSISSAUGA, Ontario — Valeant Pharmaceuticals on Thursday announced the resignation of Michael Van Every from its board of directors.

    The company said Van Every, who has served on the board since 2004, resigned due to health reasons.

  • J&J adds pain drug resources to responsible prescribing site

    RARITAN, N.J. — Johnson & Johnson has launched several new tools on a website aimed at ensuring patients with pain get the drugs they need while staying safe.

    J&J subsidiary Janssen Pharmaceuticals added resources and tools to PrescribeResponsibly.com for physicians and pharmacists to support appropriate and responsible treatment of pain. The site was originally launched early last year.

X
This ad will auto-close in 10 seconds